- Target
- PIFO
- Reactivity
- Human,Mouse
- Application
- WB,ELISA,IHC
- MW(Calculated)
- 21kD
- MW(Observed)
- --
- Host Species
- Rabbit
- Isotype
- IgG
- Conjugate/Modification
- Unmodified
- Modification site
- --
- Recommended Dilution Ratio
- WB 1:500-2000;IHC 1:50-300;ELISA 1:2000-20000
- Form
- Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
- Source
- --
- Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Purity
- --
- storageCondition
- -15°C to -25°C/1 year(Do not lower than -25°C)
- Concentration
- 1 mg/ml
- Clonality
- Polyclonal
- Clone No.
- --
- Immunogen
- Synthesized peptide derived from human PIFO AA range: 47-97
- Sequence
- --
- Specificity
- This antibody detects endogenous levels of PIFO at Human/Mouse
- Gene Name
- PIFO C1orf88
- Protein Name
- PIFO
- Other Name
- --
- Organism-1
- Human
- Gene ID-1
- 128344
- SwissProt-1
- Q8TCI5
- Organism-2
- Mouse
- Gene ID-2
- 100503311
- SwissProt-2
- Q9D9W1
- Organism-3
- --
- Gene ID-3
- --
- SwissProt-3
- --
- Organism-4
- --
- gene ID-4
- --
- SwissProt-4
- --
- Cellular Localization
- Cytoplasmic vesicle . Golgi apparatus, trans-Golgi network . Cytoplasm . Accumulates specifically at the basal body and ciliary necklace during the early steps of cilia assembly and disassembly, when structural, functional and regulatory proteins are delivered to cilia. At S phase, accumulates in vesicles and declines during mitosis. .